Healthcare -
Biotechnology - NASDAQ - US
$ 13.49
-0.369 %
$ 195 M
Market Cap
0.11
P/E
INBX - CASH & EQUIVALENTS
Cash & Equivalents INBX - Inhibrx Biosciences, Inc.
278 M
LAST VALUE
45.49%
2 YEAR CAGR
165.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR